Fair And Adequate Reimbursement Is Vital To Developing Life-Saving Medical Treatments
Reimbursement of molecular imaging and therapies - leading to the early detection and diagnosis of many life-threatening diseases - remains an urgent and critical need as consumers face ever-increasing healthcare costs. The Centers for Medicare and Medicaid Services (CMS) needs to provide fair and adequate reimbursement for effective diagnostic techniques and life-saving medical therapies - yet currently, diagnostic radiopharmaceuticals are not adequately reimbursed.